MRIs and pediatric cancer
This article was originally published in The Gray Sheet
NCI-funded trial comparing accuracy of whole-body MRI imaging with conventional imaging in detecting pediatric malignancies will use MRI scanners of 1.5 tesla or higher, including Siemens and GE systems. Preliminary results are anticipated in 18-24 months for the international American College of Radiology Imaging Network (ACRIN) trial, which began Oct. 15 and is expected to include at least 15 sites. MRI could yield cost savings and provide a streamlined and less invasive alterative to conventional imaging, which includes combinations of methods...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.